Bristol-Myers Squibb Company
Hedge Funds Holdings
Last updated:
Bristol-Myers Squibb Company‘s stocks are currently a part of 2417 hedge funds’ portfolios, which represents 71.26% of the total amount of its stocks outstanding. This makes up a total of 1.59B shares of Bristol-Myers Squibb Company. Compared to the previous quarter, the number grew by 0.34% or 5.38M shares more. As for the holding position changes, 39.51% (955) of current hedge fund investors increased the number of shares held, 39.76% (961) of current holders sold a part of the shares held, and 4.8% (116) closed the holdings completely. 195 hedge funds are new holders of Bristol-Myers Squibb Company stock in Q1 2022, it is 8.07% of total holders.
Hedge funds holding Bristol-Myers Squibb Company (Q2 2017 – Q1 2022)
Q2 2017 | 1,579 |
---|---|
Q3 2017 | 1,623 |
Q4 2017 | 1,715 |
Q1 2018 | 1,727 |
Q2 2018 | 1,671 |
Q3 2018 | 1,709 |
Q4 2018 | 1,745 |
Q1 2019 | 1,787 |
Q2 2019 | 1,750 |
Q3 2019 | 1,785 |
Q4 2019 | 2,182 |
Q1 2020 | 2,115 |
Q2 2020 | 2,156 |
Q3 2020 | 2,181 |
Q4 2020 | 2,321 |
Q1 2021 | 2,319 |
Q2 2021 | 2,323 |
Q3 2021 | 2,240 |
Q4 2021 | 2,382 |
Q1 2022 | 2,417 |
Hedge funds changes in Bristol-Myers Squibb Company positions (Q2 2017 – Q1 2022)
Q2 2017 | 110 | 567 | 650 | 86 | 166 |
---|---|---|---|---|---|
Q3 2017 | 127 | 605 | 644 | 67 | 180 |
Q4 2017 | 189 | 602 | 672 | 82 | 170 |
Q1 2018 | 127 | 582 | 775 | 92 | 151 |
Q2 2018 | 91 | 573 | 761 | 133 | 113 |
Q3 2018 | 104 | 571 | 738 | 50 | 246 |
Q4 2018 | 200 | 553 | 743 | 155 | 94 |
Q1 2019 | 186 | 716 | 661 | 129 | 95 |
Q2 2019 | 126 | 717 | 700 | 132 | 75 |
Q3 2019 | 140 | 718 | 696 | 92 | 139 |
Q4 2019 | 481 | 1,204 | 383 | 56 | 58 |
Q1 2020 | 141 | 812 | 934 | 174 | 54 |
Q2 2020 | 151 | 925 | 817 | 93 | 170 |
Q3 2020 | 134 | 880 | 898 | 97 | 172 |
Q4 2020 | 271 | 939 | 858 | 109 | 144 |
Q1 2021 | 144 | 982 | 922 | 123 | 148 |
Q2 2021 | 138 | 946 | 939 | 112 | 188 |
Q3 2021 | 97 | 960 | 865 | 154 | 164 |
Q4 2021 | 301 | 855 | 985 | 135 | 106 |
Q1 2022 | 195 | 955 | 961 | 116 | 190 |
Hedge funds changes in Bristol-Myers Squibb Company stock options (Q2 2017 – Q1 2022)
Q2 2017 | 1,821,844,547 | 1,152,324,813 |
---|---|---|
Q3 2017 | 2,960,626,285 | 1,124,174,433 |
Q4 2017 | 2,020,204,800 | 1,290,883,192 |
Q1 2018 | 2,174,053,700 | 958,734,500 |
Q2 2018 | 5,735,828,506 | 1,280,143,158 |
Q3 2018 | 191,317,244,504 | 170,069,443,344 |
Q4 2018 | 122,124,380,606 | 546,984,819,720 |
Q1 2019 | 3,189,523,748 | 2,224,383,593 |
Q2 2019 | 1,240,786,995 | 1,173,192,870 |
Q3 2019 | 77,661,845,319 | 46,519,624,544 |
Q4 2019 | 1,835,652,048 | 4,162,705,169 |
Q1 2020 | 1,417,158,068 | 116,691,336,418 |
Q2 2020 | 1,437,403,520 | 1,378,203,640 |
Q3 2020 | 153,389,928,647 | 2,330,705,044 |
Q4 2020 | 837,588,192,510 | 1,983,290,067,465 |
Q1 2021 | 163,209,280,504 | 2,706,947,544,914 |
Q2 2021 | 1,520,331,482 | 937,034,634 |
Q3 2021 | 1,566,961,485 | 2,917,607,383 |
Q4 2021 | 2,072,422,945 | 3,145,574,030 |
Q1 2022 | 2,388,522,829 | 1,613,857,009 |